Aclaris Therapeutics (ACRS) AGM 2026 summary

Opening remarks and agenda

• The meeting was called to order by the CEO and Chair, with introductions of board members, executive officers, and external advisors.

• The meeting was held virtually to facilitate stockholder participation, and the agenda and rules of conduct were provided online.

• Only validated stockholders could submit questions, limited to one per person and relevant to the meeting.

Board and executive committee updates

• Introductions included the full executive team and board members present, as well as representatives from the accounting firm and legal counsel.

Shareholder proposals

• Three proposals were presented: election of two Class II Directors, advisory vote on executive compensation, and ratification of the independent auditor.

• Stockholders were invited to comment on each proposal via the web portal.